====== 2010 ====== [[2009]]-[[2011]] In [[2010]], [[Michael T. Lawton]] et. al introduced the [[Supplementary Spetzler-Martin AVM grading scale]] specifically to predict surgical [[outcome]]s in [[Ruptured cerebral arteriovenous malformation]]. The Supplemented Spetzler-Martin grading scale also included rupture status, age of the patient, and nidal architecture (diffuse versus focal). In the 300 patients in Lawton’s 2010 study, the supplemental Spetzler-Martin grading scale demonstrated a stronger correlation with surgical outcomes than the initial [[Spetzler-Martin AVM grading system]] (ROC 0.78 vs 0.66) ((Lawton MT, Kim H, McCulloch CE, Mikhak B, Young WL. A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery. 2010 Apr;66(4):702-13; discussion 713. doi: 10.1227/01.NEU.0000367555.16733.E1. PubMed PMID: 20190666; PubMed Central PMCID: PMC2847513. )). ---- In [[2010]], the RANO criteria for [[high-grade glioma]]s was developed by a [[consensus]] of experts to update the original Macdonald criteria and account for challenges to response assessment such as [[pseudoprogression]] and [[pseudoresponse]]. Subsequent studies have suggested a limited benefit of incorporating [[T2]]/[[FLAIR]] evaluation on the correlation of [[PFS]] with [[OS]]. Moreover, some new therapies, particularly [[immunotherapy]] and viral therapies, are more likely to induce transient worsening of contrast enhancement that might lead to erroneous determination of radiographic disease progression. As a result, the modified RANO criteria were proposed in [[2017]] and differed from [[RANO]] by use of the post-radiation scan as the baseline scan, omission of FLAIR evaluation, and requirement of a confirmation scan to determine progressive disease. In 2010, [[FLAIR]] imaging was added to the [[RANO criteria]] and was recommended for the assessment of the nonenhancing component of [[glioma]]s ((Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al: Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972, 2010)). ---- Since [[2010]], surgical resection of [[insular glioma]]s is performed via [[transopercular approach]] by the Neurosurgery Clinic, [[Istanbul]] Training and Research Hospital, Departments of Neurosurgery, Cerrahpasa Medical Faculty, Istanbul University, Turkey. Clinical, surgical and follow-up results were analyzed retrospectively. The majority were low-grade (81.8%) and among them [[oligodendroglioma]] was the most common (n = 8). Half of the patients underwent [[awake craniotomy]] with [[cortical]] [[electrostimulation]] and [[total resection]] was achieved in 6 [[patient]]s. Long-term follow-up showed the majority of patients (90.9 %) were completely [[seizure]] free. Only one patient showed slight [[paresis]] on one upper extremity at the long-term follow-up. Trans-opercular approach for insular gliomas is [[safe]] and maximal [[resection]] with minimal [[neurological deficit]]s is possible. Use of [[ultrasonic aspirator]] and [[neuronavigation]] make surgery safer. Surgery-related [[complication]] is very rare. Future studies should contain larger number of patient and long-term follow-up in order to provide more accurate data ((Baran O, Akgun MY, Kemerdere R, Akcil EF, Tanriverdi T. Long-term clinical and seizure outcomes of insular gliomas via trans-opercular approach. Clin Neurol Neurosurg. 2018 Aug 2;173:52-57. doi: 10.1016/j.clineuro.2018.08.001. [Epub ahead of print] PubMed PMID: 30086428. )). ---- [[Brain death]] was defined according to the [[2010]] [[American Academy of Neurology]] guidelines and following [[2020]] [[The World Brain Death Project]] ---- De Ridder et al. published in [[2010]] a cohort of 12 patients who underwent the so-called “[[burst stimulation]]” ((De Ridder D, Vanneste S, Plazier M, van der Loo E, Menovsky T. Burst spinal cord stimulation: toward paresthesia-free pain suppression. Neurosurgery. 2010 May;66(5):986-90. doi: 10.1227/01.NEU.0000368153.44883.B3. PubMed PMID: 20404705. )). ---- [[World Neurosurgery]] is a bimonthly [[peer review]]ed medical [[journal]] that was established in [[1973]] as [[Surgical Neurology]] before obtaining its current name in [[2010]]. It is published by [[Elsevier]] and is the official journal of the [[World Federation of Neurosurgical Societies]]. ---- With the passage of the [[Affordable Care Act]] in 2010, healthcare metrics and patient outcomes, especially mortality rates, are increasingly emphasized as integral measures of overall quality of care and hospital reimbursements ((Hammers R, Anzalone S, Sinacore J, Origitano TC. Neurosurgical mortality rates: what variables affect mortality within a single institution and within a national database? J Neurosurg. 2010;112(2):257-26.)) ((Spurgeon A, Hiser B, Hafley C, Litofsky NS. Does improving medical record documentation better reflect severity of illness in neurosurgical patients? Neurosurgery. 2011;58:155-163.)) ((Zalatimo O, Ranasinghe M, Harbaugh RE, Iantosca M. Impact of improved documentation on an academic neurosurgical practice. J Neurosurg. 2014;120(3):756-763.)) ((Reyes C, Greenbaum A, Porto C, Russell JC. Implementation of a clinical documentation improvement curriculum improves quality metrics and hospital charges in an Academic Surgery Department. J Am Coll Surg. 2017;224:301-309.)). ---- In [[2010]], the [[O'Kelly-Marotta grading scale]] was proposed as a method of assessing the degree of angiographic filling and contrast stasis in the setting of [[intracranial aneurysm]]s treated by [[endovascular]] [[flow diversion]]. Taking into account the dynamic nature of the contrast stasis, it is designed for use with [[cerebral angiography]] to predict aneurysm closure over time ((O'Kelly CJ, Krings T, Fiorella D, Marotta TR. A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents. Interv Neuroradiol. 2010;16:133–137.)).